Keyphrases
Levofloxacin
100%
Antimicrobial Susceptibility Pattern
100%
Bacterial Isolates
100%
Recurrent Urinary Tract Infections (rUTIs)
100%
Surveillance Program
100%
Bacterial Strains
66%
Escherichia Coli
66%
Japanese Society
66%
Minimum Inhibitory Concentration
66%
Resistant Strains
66%
Japan
33%
Clinically Significant
33%
Klebsiella Pneumoniae (K. pneumoniae)
33%
Infectious Diseases
33%
Chemotherapy
33%
Vancomycin
33%
Fluoroquinolones
33%
Pseudomonas Aeruginosa (P. aeruginosa)
33%
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
33%
Extended-spectrum-lactamase
33%
Enterococcus Faecalis
33%
Bacterial Pathogens
33%
Methicillin-resistant Staphylococcus Aureus
33%
Carbapenem-resistant Enterobacteriaceae
33%
Escherichia Coli Strains
33%
Downward Trend
33%
Survey Results
33%
Medical Institutions
33%
Susceptible Strain
33%
Proteus Mirabilis
33%
Clinical Microbiology
33%
National Surveillance Data
33%
National Surveillance
33%
Pharmacology, Toxicology and Pharmaceutical Science
Escherichia coli
100%
Levofloxacin
100%
Urinary Tract Infection
100%
Antiinfective Agent
100%
Pseudomonas aeruginosa
66%
Minimum Inhibitory Concentration
66%
Chemotherapy
33%
Klebsiella pneumoniae
33%
Quinolone Derivative
33%
Infectious Agent
33%
Penicillinase
33%
Enterococcus faecalis
33%
Infection
33%
Vancomycin
33%
Methicillin-Resistant Staphylococcus Aureus
33%
Proteus mirabilis
33%
Carbapenem Resistant Enterobacteriaceae
33%
Immunology and Microbiology
Escherichia coli
100%
Urinary Tract
100%
Antibiotic Sensitivity
100%
Bacterial Strain
66%
Minimum Inhibitory Concentration
66%
Pseudomonas aeruginosa
66%
Infectious Disease
33%
Infectious Agent
33%
Methicillin-Resistant Staphylococcus Aureus
33%
Enterococcus faecalis
33%
Carbapenem Resistant Enterobacteriaceae
33%
Klebsiella pneumoniae
33%
Clinical Microbiology
33%
Proteus mirabilis
33%